Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Goudsmit

Showing results (321-330 of 424) with videos related to

Pageof 43
Sort By:
The Journal of Infectious Diseases|January 1, 1992
Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjectsC A Boucher, E O'Sullivan, J W Mulder, et al.
Pediatrics|October 1, 1986
Neurologic manifestations of human immunodeficiency virus infection in childrenL G Epstein, L R Sharer, J M Oleske, et al.
The Journal of Infectious Diseases|September 18, 1997
High-dose interferon-alpha2a exerts potent activity against human immunodeficiency virus type 1 not associated with antitumor activity in subjects with Kaposi's sarcomaP H Frissen, F de Wolf, P Reiss, et al.
AIDS (London, England)|November 8, 2001
Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strainsJ Goudsmit, G J Weverling, L van der Hoek, et al.
AIDS (London, England)|August 17, 1999
HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDSA Abebe, D Demissie, J Goudsmit, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 26, 2021
Joint modeling of liver transplant candidates outperforms the model for end-stage liver disease: The effect of disease development over time on patient outcomeBen F J Goudsmit, Andries E Braat, Maarten E Tushuizen, et al.
Hepatology (Baltimore, Md.)|December 10, 2020
Refitting the Model for End-Stage Liver Disease for the Eurotransplant RegionBen F J Goudsmit, Hein Putter, Maarten E Tushuizen, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individualsP Reiss, F de Wolf, C L Kuiken, et al.
Hepatology (Baltimore, Md.)|February 17, 2025
Erratum: Refitting the model for end-stage liver disease for the eurotransplant regionBen F J Goudsmit, Hein Putter, Maarten E Tushuizen, et al.
Journal of Clinical Laboratory Analysis|January 1, 1990
Immune response and epitope mapping of a candidate HIV-1 p17 vaccine HGP30C A Boucher, W J Krone, J Goudsmit, et al.
Pageof 43

Showing results (321-330 of 424) with videos related to

Sort By:
Pageof 43
The Journal of Infectious Diseases|January 1, 1992
Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjectsC A Boucher, E O'Sullivan, J W Mulder, et al.
Pediatrics|October 1, 1986
Neurologic manifestations of human immunodeficiency virus infection in childrenL G Epstein, L R Sharer, J M Oleske, et al.
The Journal of Infectious Diseases|September 18, 1997
High-dose interferon-alpha2a exerts potent activity against human immunodeficiency virus type 1 not associated with antitumor activity in subjects with Kaposi's sarcomaP H Frissen, F de Wolf, P Reiss, et al.
AIDS (London, England)|November 8, 2001
Carrier rate of zidovudine-resistant HIV-1: the impact of failing therapy on transmission of resistant strainsJ Goudsmit, G J Weverling, L van der Hoek, et al.
AIDS (London, England)|August 17, 1999
HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDSA Abebe, D Demissie, J Goudsmit, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 26, 2021
Joint modeling of liver transplant candidates outperforms the model for end-stage liver disease: The effect of disease development over time on patient outcomeBen F J Goudsmit, Andries E Braat, Maarten E Tushuizen, et al.
Hepatology (Baltimore, Md.)|December 10, 2020
Refitting the Model for End-Stage Liver Disease for the Eurotransplant RegionBen F J Goudsmit, Hein Putter, Maarten E Tushuizen, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individualsP Reiss, F de Wolf, C L Kuiken, et al.
Hepatology (Baltimore, Md.)|February 17, 2025
Erratum: Refitting the model for end-stage liver disease for the eurotransplant regionBen F J Goudsmit, Hein Putter, Maarten E Tushuizen, et al.
Journal of Clinical Laboratory Analysis|January 1, 1990
Immune response and epitope mapping of a candidate HIV-1 p17 vaccine HGP30C A Boucher, W J Krone, J Goudsmit, et al.
Pageof 43